Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,160) with videos related to
Page
of 116
Sort By:
Investigative Ophthalmology & Visual Science
|
July 23, 2016
Cone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency
Emily J Patterson, Melissa Wilk, Christopher S Langlo, et al.
Journal of the American College of Cardiology
|
May 30, 2009
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease
Tjun Y Tang, Simon P S Howarth, Sam R Miller, et al.
Retina (Philadelphia, Pa.)
|
February 2, 2017
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA
Christopher S Langlo, Laura R Erker, Maria Parker, et al.
Leukemia
|
September 17, 2021
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Blood
|
June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance
Guang Yang, Jinhua Wang, Li Tan, et al.
Blood Cancer Journal
|
July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia
Maria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
Molecular Psychiatry
|
November 17, 2004
Support for involvement of neuregulin 1 in schizophrenia pathophysiology
T L Petryshen, F A Middleton, A Kirby, et al.
Journal of the Advanced Practitioner in Oncology
|
October 6, 2022
Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center Experience
Fedricker D Barber, Erick Campbell, Yuko Yamamura, et al.
British Journal of Haematology
|
April 20, 2025
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P Treon, Lian Xu, Maria Luisa Guerrera, et al.
Page
of 116
Search research articles
Search
Showing results (1131-1140 of 1,160) with videos related to
Sort By:
Page
of 116
Investigative Ophthalmology & Visual Science
|
July 23, 2016
Cone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency
Emily J Patterson, Melissa Wilk, Christopher S Langlo, et al.
Journal of the American College of Cardiology
|
May 30, 2009
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease
Tjun Y Tang, Simon P S Howarth, Sam R Miller, et al.
Retina (Philadelphia, Pa.)
|
February 2, 2017
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA
Christopher S Langlo, Laura R Erker, Maria Parker, et al.
Leukemia
|
September 17, 2021
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Blood
|
June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance
Guang Yang, Jinhua Wang, Li Tan, et al.
Blood Cancer Journal
|
July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia
Maria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
Molecular Psychiatry
|
November 17, 2004
Support for involvement of neuregulin 1 in schizophrenia pathophysiology
T L Petryshen, F A Middleton, A Kirby, et al.
Journal of the Advanced Practitioner in Oncology
|
October 6, 2022
Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center Experience
Fedricker D Barber, Erick Campbell, Yuko Yamamura, et al.
British Journal of Haematology
|
April 20, 2025
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P Treon, Lian Xu, Maria Luisa Guerrera, et al.
Page
of 116